Real-world outcomes of haplo-HSCT with post-transplant cyclophosphamide in pediatric hematologic malignancies: a study on behalf of SFGM-TC and SFCE

Bone Marrow Transplant. 2025 Jun;60(6):917-920. doi: 10.1038/s41409-025-02584-4. Epub 2025 Apr 13.
No abstract available

Publication types

  • Letter